risk analysis, page-15

I have been in the same boat for 5 years now, ridden the peaks and troughs.

I am also in the industry for 20 years and work overseas in Europe,so have been through a lot of clinical trials (successes as well as failures) its important to remember delays are usual and mostly not bad news (bad news needs o be reported quickly for the sake of the patients,regulators and the physicians.)Management may simply be in a position where they can't report anything at the moment to the outside world.
The other point of encouragement is that the new Chairman is highly credible within the industry from a global perspective. He is not a light weight and by taking this position he has to be fairly confident it isn't going to fall apart within 6 months (not good on his CV). the timing of his placement is pivotal in my opinion.